Antibiotic Resistance Involves Antimicrobial Inactivation in Global Communities

The science of ageing has become of critical interest to the antimicrobial drug industry with aging and geriatric medicine associated with antibiotic resistance and mitochondrial apoptosis with relevance to the global chronic disease epidemic. In the United States and Europe the geriatric population (> 65 years) is expected to double by the year 2060 with the death rate in the European Union in the geriatric population to be greater than 80% when compared with individuals <65 years